Yahoo Web Search

Search results

1. • 

     Lung cancer is the deadliest of all cancers, and screening could save many lives − if more people...

     The Conversation via Yahoo News· 2 weeks ago

     Lung cancer screening can save lives, but it isn't accessible to everyone at risk of developing the...

2. • 

     Cancer cases could increase 77% as global population balloons. These types are most common.

     USA TODAY via Yahoo News· 2 months ago

     The release of 2022 cancer data gives the latest look into which types of cancer are most prevalent...

3. • 

     Quest Diagnostics' (DGX) Haystack Oncology Inks New Deal

     Zacks via Yahoo Finance· 5 months ago

     Quest Diagnostics’ DGX subsidiary, Haystack Oncology, recently announced a collaboration with the...

4. • 

     Gilead Snags Another Cancer Win On The Heels Of Its Best Growth In 7 Years

     Investor's Business Daily· 1 year ago

     Gilead Sciences followed up a strong quarterly report with a third Food and Drug Administration...

5. • 

     'Amazing' start to new year as Statesman Season for Caring program raises more than $1.4M

     Austin American-Statesman via Yahoo News· 5 months ago

     Christmas morning in Kristin Ramirez's house was just one word: "Amazing." Presents from Grisham...

6. • 

     2 Under-the-Radar Biotech Stocks to Buy in 2023

     Motley Fool· 1 year ago

     Let's take a look at these innovative under-the-radar biotech stocks to add to your portfolio this year. Seagen (NASDAQ: SGEN) sells four drugs for...

7. • 

     Novartis (NVS) Up 10.8% YTD on Strong Q1, Pipeline Progress

     Zacks via Yahoo Finance· 1 year ago

     Shares of Novartis NVS have gained 10.8% in the year so far compared with the industry’s 1.6%...

8. • 

     Analyst Moves To Sidelines After Jazz Pharma Deal Shifts Zymeworks To Early Stage Pipeline

     Benzinga via Yahoo Finance· 2 years ago

     SVB Leerink downgraded Zymeworks Inc (NASDAQ: ZYME) to Market Perform with a price target of $8,...

9. • Atossa Therapeutics Inc (ATOS) Year-End Earnings: A Comprehensive Analysis

     GuruFocus.com via Yahoo Finance· 2 months ago

     Operating Expenses: Increased to $31.4 million in 2023, up from $27.7 million in 2022. Research and Development (R&D) Expenses: Rose to $17.3 million, with significant investment in clinical ...

10. • 

      Here's what it's like to have your fallopian tubes removed

      Yahoo Life· 1 year ago

      Ovarian cancer — the deadliest of all gynecologic cancers — has no cure or reliable screening...